Cocco G, Iselin H U, Strozzi C, Cesana B, Baumeler H R
Eur J Clin Pharmacol. 1987;32(4):335-8. doi: 10.1007/BF00543964.
Sixty patients were treated for 1 year for essential uncomplicated hypertension, 30 with beta-blockers alone (BB) and 30 with BB and chlorthalidone (CTD). BB did not affect serum K+ or Mg++. In the BB-group there was a statistically significant trend towards retention of Mg++ in a loading test, but the effect was clinically marginal. BB + CTD reduced serum K+ and Mg++ and caused significant Mg++ depletion, as shown by the Mg++ loading test. All the effects were highly significant and were clinically important. The metabolic perturbations due to CTD are potentially dangerous and make this drug unattractive as 'first choice' treatment for hypertension.
60例原发性单纯性高血压患者接受了为期1年的治疗,其中30例仅使用β受体阻滞剂(BB)治疗,30例使用BB联合氯噻酮(CTD)治疗。BB对血清钾离子(K⁺)或镁离子(Mg²⁺)无影响。在BB组,负荷试验中存在镁离子潴留的统计学显著趋势,但该效应在临床上微不足道。BB + CTD降低了血清K⁺和Mg²⁺水平,并导致显著的镁离子缺乏,如镁离子负荷试验所示。所有这些效应都非常显著且具有临床重要性。CTD引起的代谢紊乱具有潜在危险性,使得该药物作为高血压的“首选”治疗药物缺乏吸引力。